FDA

« Back to Glossary Index

U.S. Food and Drug Administration

Related Articles:

Breakthrough Drug Offers New Hope for Advanced Alzheimer’s
Memantine shown to be effective against the later stages of Alzheimer's offers new hope for treating the illness at a time when patients and caregivers need it most.
Drug for Late Alzheimer’s Moves Closer to Approval
Memanatine (brand name Namenda) may offer a new option for the later stages of Alzheimer's disease.
New Drug, Alzhemed, Shows Early Promise Against Alzheimer’s
Namenda, the first drug shown to have benefits against moderate to severe Alzheimer's, approved for U.S. sale.
Facts about Alzheimer’s
The Latest News on Alzheimer’s Disease and Brain Health

« Back to Glossary Index

Add Impact to Your Inbox

Be in the know about what’s going on concerning Alzheimer’s and Dementia

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

WE CAN END ALZHEIMER'S

We support pioneering Alzheimer's research in search for a cure.

DONATE FOR THE CURE

We consistently receive top awards and ratings for our accountability:

Charity Navigator

GuideStar Gold Seal of Transparency

America's Best Charities

Combined Federal Campaign

Health and Medical Research Charities of America

2026 Hermes Creative Award